Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for u...
Boston Scientific Corp. (BSX) has a valuation score of 95/100 (strong), profitability score of 77/100 (strong), financial health score of 73/100 (moderate), Piotroski F-Score of 7/9, Altman Z-Score of 2.80 (grey zone), revenue growth of +16.5% YoY.
Neutral
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026
Analyst Recommendations38 analysts · 2026-08-01
11
19
8
Strong Buy 11Buy 19Hold 8Sell 0Strong Sell 0
Recent Market Moves
See all BSX moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 26 | Pre-market | $47.05 | -5.64% | -3.76 |
| Aug 26 | Regular | $48.34 | -3.04% | -2.03 |
| Aug 5 | Regular | $47.41 | -3.43% | -2.29 |
| Aug 3 | Regular | $48.30 | +3.37% | 2.25 |
| Aug 3 | After-hours | $48.79 | +4.41% | 2.94 |